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the ACC (r = –0.72, p  ! 0.001), but this association disap-
peared when controlling for cardiovascular risk factors (p = 
0.21). In comparison to patients who were non-depressed at 
3 months after hospitalization (n = 14), patients with persis-
tent depressive symptoms (n = 8) exhibited more advanced 
deep white matter changes overall (p  ! 0.02), but not when 
controlling for cardiovascular comorbidity. Persistently de-
pressed patients also had lower fractional anisotropy in the 
ACC (p  ! 0.05), but this effect disappeared when controlling 
for modifiable cardiovascular risk factors.  Conclusions: This 
study provides the first evidence that persistent depressive 
symptoms after ACS are associated with vascular brain 
changes. Longitudinal studies are needed to determine 
whether depressive symptoms precede these changes or 
vice versa.  Copyright © 2010 S. Karger AG, Basel 
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 Abstract 
 Background: Persistent depressive symptoms after acute 
coronary syndrome (ACS) are common and increase the risk 
of recurrent cardiac events and mortality. However, the neu-
robiological correlates of post-ACS depressive symptoms 
have not yet been studied.  Methods: Three months after 
ACS, 22 patients were scanned for the presence of cerebral 
deep white matter changes and microstructural abnormali-
ties in the anterior cingulate cortex (ACC) and dorsolateral 
prefrontal cortex. We used the Coffey Rating Scale of deep 
white matter changes and measures of fractional anisotropy 
derived from diffusion tensor imaging. Patients also com-
pleted the Beck Depression Inventory, and the number of 
cardiovascular comorbidities as well as modifiable cardio-
vascular risk factors were assessed.  Results: Controlling for 
cardiovascular comorbidity, depressive symptom severity at 
3 months was negatively related to fractional anisotropy in 
 Received: July 14, 2009 
 Accepted after revision: November 1, 2009 
 Published online: February 20, 2010 
 Michael A. Rapp, MD, PhD 
 Department of Psychiatry, Geriatric Psychiatry Center 
 Charité Campus Mitte, Psychiatric University Clinic at St. Hedwig’s Hospital
Grosse Hamburger Strasse 5–11,  DE–10115 Berlin (Germany) 
 Tel. +49 30 2311 2959, E-Mail michael.rapp  @  charite.de 
 © 2010 S. Karger AG, Basel
 
 Accessible online at:
www.karger.com/pps 
M.A.R. and N.R. contributed equally to the manuscript.
Innovations
 Rapp /Rieckmann /Lessman /Tang /
Paulino /Burg /Davidson 
Psychother Psychosom 2010;79:149–155150
 Introduction 
 Structural MRI studies in elderly patients with vascu-
lar depression  [1, 2] have reported increased deep white 
matter lesions  [3, 4] ; however, white matter changes have 
also been reported in elderly patients with depression on-
set at an earlier age  [5] , and may extend to younger age 
groups  [6] . Specifically, white matter changes in the ante-
rior cingulate circuit  [7] , and the dorsolateral prefrontal 
cortex (DLPFC) have been identified in vascular depres-
sion  [3, 4, 6–8] . These brain areas have been implicated 
in emotional regulation in humans  [9] , suggesting a di-
rect link between the structural changes caused by vas-
cular lesions and subsequent negative mood states.
 After acute coronary syndrome (ACS), depressive 
symptoms are common  [10, 11] . In several studies and 2 
meta-analyses, depressive symptoms emerged as reliable 
predictors of subsequent all-cause mortality as well as re-
hospitalization for cardiac events, even at low levels of 
depression  [12–14] . This relationship follows a dose-re-
sponse fashion – the more severe the depressive symp-
toms, the higher the risk  [15] – and there is some evidence 
that patients with depressive symptoms that persist across 
several months appear to be at highest risk for poor out-
comes  [12, 16, 17] .
 Several biological correlates of depression and vascu-
lar disease have been proposed to explain the risk con-
ferred by persistently elevated depressive symptoms [for 
review, see  18 ], including elevated inflammatory markers 
 [19] and dysregulation of the hypothalamic-pituitary-ad-
renal axis with subsequent changes in autonomic cardiac 
function  [20] . However, the neurobiological correlates of 
post-ACS depressive symptoms have not yet been studied 
empirically. Studies showing a high comorbidity between 
cardiovascular disease and depression – in which about 
30% of patients experience elevated depressive symptoms 
after an ACS and 20% have major depressive disorder
 [21] – suggest that at least in some patients, depressive 
symptoms may be of vascular origin. Using MRI, vascu-
lar lesions have traditionally been assessed using stan-
dardized rating scales  [22] that quantify vascular chang-
es at the macrostructural level. An alternative method is 
diffusion tensor imaging, which employs MRI techniques 
to measure alterations in brain tissue microstructure 
 [23] .
 We explored the relationship between depressive 
symptoms after an ACS (assessed at hospitalization and 
after 3 months) and macro- and microstructural abnor-
malities in the brain (assessed 3 months after the ACS). 
Specifically, we assessed the relationship between the se-
verity of depressive symptoms and measures of fraction-
al anisotropy in the anterior cingulate cortex (ACC) and 
DLPFC, and the extent of deep white matter hyperinten-
sities. We further compared post-ACS patients who had 
persistently elevated depressive symptoms to those who 




 Participants were a subsample of the Coronary Psychosocial 
Evaluation Studies (COPES) that included a consecutive sample 
of ACS patients who were admitted to the coronary care units of 
3 university hospitals between May 1, 2003 and June 13, 2005. Di-
agnosis of ACS was determined by research criteria [for details, 
see  24 ]. Patients were included in the study if they met pre-speci-
fied depressive symptom levels according to the Beck Depression 
Inventory (BDI  [13] ), i.e. scores  6 10 or  ! 5. A BDI score of 10 or 
higher indicates elevated depressive symptoms, and has been as-
sociated with increased mortality and recurrent cardiac event risk 
after ACS  [11] .
 Patients were recruited after Institutional Review Board ap-
proval and informed consent. Recruitment for the MRI substudy 
took place at the Mount Sinai site only; of the 189 patients enrolled 
at the site, only 36 (19%) agreed to take part in the MRI study at 
3 months. Of these, 14 participants were excluded because of me-
tallic implants other than cardiac stents (n = 2), claustrophobia
(n = 2), active alcohol or substance abuse (n = 2), cognitive im-
pairment as indicated by a Mini-Mental State Examination 
(MMSE  [25] ) score  ! 24 (n = 1), scanner downtime  1 4 weeks (n = 
3), and poor data quality (n = 3). The remaining sample (n = 22) 
did not differ from the parent sample in terms of age, sex, ethnic-
ity, BMI, smoking, the number of cardiovascular diagnoses, and 
depression history (all p  1 0.21).
 Clinical Variables 
 At baseline, within 1 week of hospitalization for ACS, patients 
completed a demographic form assessing age, sex, and ethnicity. 
Height and weight were measured, and their smoking status as-
sessed (never smoked vs. ever smoked vs. non-smoker; in pack 
years). They were administered the MMSE [25]  and the BDI  [26] . 
The BDI was re-administered 3 months after enrollment. Patients 
who had a score of  6 10 on the BDI at both baseline (in hospital) 
and after 3 months were considered ‘persistently depressed’.
 All participants also underwent a semi-structured diagnostic 
interview (Depression Interview and Structured Hamilton  [27] ) to 
determine the presence of major and minor depressive disorder 
according to the DSM-IV criteria, including lifetime history of 
depressive illness  [28] . Previous cardiovascular and metabolic di-
agnoses (history of peripheral vascular disease, hypercholesterol-
emia, diabetes, recurrent angina, history of hypertension, con-
gestive heart failure) were collected from medical charts and 
summed. Severity of the index ACS was coded according to clini-
cal criteria  [29] as unstable angina, ST-segment elevation myocar-
dial infarction, and non-ST-segment elevation myocardial infarc-
tion. Treatment of the index ACS episode was assessed in 5 catego-
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ries (no treatment; cardiac catheterization; thrombolysis; coronary 
artery bypass graft; other). The course of the index ACS during the 
first 3 months was coded dichotomously as a function of the num-
ber of clinical interventions (emergency room visits; hospitaliza-
tions; cardiac catheterization; thrombolysis; coronary artery by-
pass graft; other) needed during the follow-up period (0 = no in-
tervention needed; 1 = one or more interventions needed).
 MRI Procedures 
 Scanning was performed using a 1.5-T Siemens Vision Scan-
ner at the Mount Sinai School of Medicine. Patients received an 
MPRAGE (3D-magnetization-prepared rapidly acquired gradi-
ent echo) scan [repetition time (TR) = 2,500 ms, echo time
(TE) = 4.38 ms, matrix = 256  ! 256, field of view (FOV) = 210 
mm, number of excitations (NEX) = 1, slice thickness = 0.8 mm, 
208 slices, no gap, inversion time (TI) = 1,100 ms], a fast dual-spin 
echo scan (TR = 6,250 ms, TE = 14/96 ms, matrix = 256  ! 256, 
FOV = 210 mm, slice thickness = 3 mm, 45 slices, no gap), a FLAIR 
(fluid-attenuated inversion recovery) scan (TR = 8,340 ms, TE = 
2,500 ms, matrix = 320  ! 320, FOV = 230 mm, NEX = 1, slice 
thickness = 3 mm, 40 slices, no gap), and a diffusion tensor scan 
(TR = 5,100 ms, TE = 80 ms, matrix = 128  ! 128, FOV = 220 mm, 
NEX = 7, slice thickness = 3 mm, 40 slices, no gap, b = 1,250
s/mm 2 ). Twelve diffusion sensitization directions were used.
 Coffey Scale 
 The Coffey classification system  [22] was used to describe the 
extent of deep white matter hyperintensities on anatomical scans. 
This grading system rates deep white matter lesions on a 4-point 
scale (absent, punctuate, confluent, or large). Two raters (M.A.R., 
D.A.L.), who were blinded to group membership, rated the scans. 
Inter-rater reliability was satisfactory (r = 0.83).
 Image Processing 
 In-house software (CYT) was used to compute the anisotropy 
and vector maps. MEDx v3.4.3 software (Medical Numerics Inc., 
Sterling, Va., USA) was used to inspect and define regions of in-
terest (ROIs) in the ACC and DLPFC on the fractional anisotropy 
images. Two adjacent axial planes were selected to contain the 
same voxel locations. ROI dimensions for the fractional anisot-
ropy images were set to 3  ! 3. Each 3 ROIs were placed in ACC 
and DLPFC. Fractional anisotropy values of the white matter un-
derlying each ROI were averaged for each area and extracted. 
Fractional anisotropy data were missing for 3 patients (2 did not 
complete scanning, 1 due to accidental data loss).
 Statistical Analyses 
 The   2 test for categorical variables and t test for continuous 
variables were used to assess depression group differences in de-
scriptive variables and covariates. The associations between de-
pression severity, depression groups, and Coffey scores were ex-
amined using non-parametric statistics (Kendall’s tau b and   2 
test). For non-parametric analyses of covariance, we used a logis-
tic regression approach to control for covariates at each dichoto-
mous category step (e.g. for the Coffey scale, absent vs. punctuate, 
punctuate vs. confluent, and confluent vs. large) and then com-
pared the residuals as a function of depression group using   2 tests 
[for a similar approach, see  30 ]. Fractional anisotropy measures 
were treated as continuous variables; bivariate Pearson correla-
tions were used to assess the relation between fractional anisot-
ropy measures and depressive symptom severity, and hierarchical 
linear regression was used to control for potential covariates. Uni-
variate ANOVA was used to assess depression group differences 
in fractional anisotropy measures; analysis of covariance was 
used to control for covariates. Two-tailed tests of significance 
were employed with   set at  ! 0.05. All analyses were performed 
using statistical software (SPSS Inc., Chicago, Ill., USA).
 Results 
 Demographic and Clinical Characteristics 
 The overall study group (n = 22) comprised 9 women 
(40.9%) and 13 men, with a mean age of 56.09 years
(SD = 9.53). At baseline, 16 patients had significant depres-
sive symptoms, and 6 were non-depressed. Eight patients 
remained persistently depressed after 3 months (BDI score 
 6 10), the other 14 remained non-depressed or remitted to 
a BDI score  ! 10 by 3 months. No patient developed new 
significant depressive symptoms during that time.
 Table 1 displays the demographic characteristics of 
persistently depressed patients in comparison to patients 
without depression or those with transient depressive 
symptoms only. 
 White Matter Lesions (Coffey Scale) 
 Depressive symptoms at 3 months were significantly 
correlated with white matter lesions (  = 0.41, p  ! 0.02). 
A similar albeit weaker and non-significant correlation 
was observed for depressive symptoms at baseline (  = 
0.20, p = 0.24).
 Patients with persistent depressive symptoms exhibited 
more advanced deep white matter changes, as assessed by 
the Coffey Scale, compared to post-ACS patients with no 
or transient depressive symptoms (  2 = 5.25, d.f. = 1, p  ! 
0.02;  fig. 1 ). This difference remained significant when ad-
justing for age, sex, ethnicity, BMI, and smoking status
(  2 = 4.47, d.f. = 1, p  ! 0.03). When controlling for the 
number of cardiovascular diagnoses, including diabetes, 
however, this effect diminished (p = 0.31). Neither the type 
of treatment (p = 0.34) nor the severity (p = 0.18) nor the 
course (p = 0.48) of the ACS index episode had an effect 
on deep white matter changes. In addition, the presence 
versus absence of a lifetime history of depression did not 
have an effect on deep white matter changes (p = 0.21).
 Fractional Anisotropy in the ACC and the 
Dorsolateral Prefrontal Circuit 
 Fractional anisotropy in the ACC was significantly re-
lated to depression severity at 3 months (r = –0.72, p  ! 
0.001;  fig. 2 ). This association remained significant when 
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Table 1. Demographic and clinical characteristics of patients with no/transient depressive symptoms and patients with persistent de-
pressive symptoms
No/transient depressive
symptoms (n = 14)
Persistent depressive
symptoms (n = 8)
p
Age, years 56.14810.60 56.088.0 0.97
Females 4 (28.6) 5 (62.5) 0.19
Hispanic 3 (21.4) 5 (62.5) 0.08
Smoking, pack years 21.94818.49 24.60836.89 0.85
MMSE score 29.7980.43 29.1381.25 0.08
Previous cardiovascular diagnoses (including diabetes) 3.1584.86 2.6381.23 0.77
Index ACS
Unstable angina 6 (42.9) 5 (62.5)
0.34
Non-ST-segment elevation myocardial infarction 2 (14.3) 2 (25.0)
ST-segment elevation myocardial infarction 6 (42.9) 1 (12.5)
Treatment of index ACS
Catheterization 9 (64.3) 4 (50.0)
Thrombolysis 4 (28.6) 3 (37.5)
Coronary artery bypass surgery 1 (7.1) 0 (0.0)
Other 0 (0.0) 1 (12.5) 0.62
Interventions needed in first 3 months after ACS 11 (78.6) 7 (87.5) 0.60
Body mass index 26.3482.4 32.8685.34 0.001
BDI score at 3 months 2.8682.89 16.8883.60 <0.001
Depressive disorder status at 3 months
Minor depression 0 5 (62.5) <0.001Major depressive episode 0 2 (25.0)
History of depression 7 (50.0) 7 (50.0) 0.67
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 Fig. 1. Deep white matter lesions as a function of depressive symp-
tom stability 3 months after ACS. 
 Fig. 2. Relationship between depression severity and fractional 
anisotropy in the ACC at 3 months after ACS. Three patients are 
missing fractional anisotropy data (n = 19, see ‘Methods’). 
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controlling for sex, ethnicity, smoking status, body mass 
index, and number of cardiovascular diagnoses (  =
–0.66, p  ! 0.05). Fractional anisotropy in the ACC was 
not, however, significantly related to depressive symptom 
severity at baseline (r = –0.23, p = 0.34). Neither the type 
of treatment, nor the severity, nor the course of the ACS 
index episode had an effect on fractional anisotropy in the 
ACC (all p  1 0.32) or DLPFC (all p  1 0.53). In addition, the 
presence versus absence of a lifetime history of depres-
sion did not have an effect on fractional anisotropy (p = 
0.27).
 In comparison to patients with no or only transient 
depressive symptoms, patients with persistent depressive 
symptoms had significantly lower fractional anisotropy 
in the ACC (F 1, 17 = 9.74, p  ! 0.01,   2 = 0.36). This differ-
ence remained significant when controlling for age, sex, 
ethnicity, and the number of vascular diagnoses, includ-
ing diabetes, and the severity, course, and treatment of 
the index ACS (F 6, 13 = 5.29, p  ! 0.05,   2 = 0.31), but dis-
appeared when controlling for modifiable risk factors of 
BMI and smoking in pack years (p = 0.28). There was no 
association between depressive symptom severity or de-
pression group and lower fractional anisotropy in the 
DLPFC (p = 0.46 and 0.97, respectively).
 Discussion 
 We found distinct differences in macrostructural deep 
white matter changes in post-ACS patients as assessed by 
semi-quantitative ratings (Coffey Scale  [22] ) as a function 
of depressive symptom severity and persistence after 3 
months. This difference remained significant when con-
trolling for modifiable risk factors, but disappeared when 
controlling for the number of cardiovascular diseases. 
Furthermore, we found a significant relationship be-
tween fractional anisotropy, reflecting microstructural 
changes in the ACC, and depressive symptom severity 
and persistence. This association remained significant 
when controlling for cardiovascular diseases; however, 
when controlling for modifiable risk factors, this associa-
tion was not significant anymore.
 Our findings show that depression after ACS is asso-
ciated with vascular brain lesions in an area critical to 
the pathophysiology of depression  [7–9] , suggesting that 
in some patients, post-ACS depression is related to vas-
cular lesions consistent with models of vascular depres-
sion  [1, 2] and earlier findings of depression persistence 
in the presence of vascular brain changes, both on the 
microstructural  [7, 8] and the macrostructural  [2–4] 
levels. We propose that white matter changes on the mi-
cro- and macrostructural levels may both contribute to 
depression vulnerability  [11] in post-ACS patients, may 
perpetuate depression beyond adjustment processes af-
ter ACS  [12, 13] , and may be a critical biomarker for the 
depression-mortality association reported after ACS 
 [11–16] . Our findings suggest that the severity of cardio-
vascular disease mediates the association between de-
pression and macrostructural changes, whereas modifi-
able risk factors mediate the association between de-
pression and microstructural changes. However, it has 
to be noted that directional causality cannot be inferred 
from our data, and there is indeed evidence that depres-
sion may precede cerebrovascular lesions and risk fac-
tors  [31, 32] .
 Several limitations have to be considered. First, we 
cannot rule out the possibility that other biological mech-
anisms, such as inflammatory response  [19] and dysregu-
lation of the hypothalamic-pituitary-adrenal axis with 
subsequent changes in autonomic cardiac function  [20] , 
may be related to vascular changes in post-ACS depres-
sion, since we lack these data in our study. Second, the 
extent of cerebrovascular lesions could be related to the 
severity of cardiovascular comorbidities, but we lack spe-
cific data on the severity of these diagnoses in our sample. 
Treatment of the index ACS, however, including the use 
of stenting, did not explain the observed differences in 
cerebrovascular lesions in our study. Third, this study is 
limited by its small sample size and limited number of 
patients with major depressive disorder. This did not al-
low us to examine the contribution of specific depressive 
disorder subtypes that have recently been shown to pre-
dict post-ACS mortality and event recurrence, such as the 
distinction between incident and recurrent major depres-
sive episode  [33, 34] . In that realm, the study provides 
only preliminary data and is of pilot nature.
 Given the finding that cardiovascular diagnoses ac-
count for a significant amount of variance in macrostruc-
tural (deep white matter) changes, while cardiovascular 
risk factors account for a significant amount of variance 
in microstructural changes (fractional anisotropy), one 
may speculate that modifiable risk factors may have a 
specific impact on microstructural changes associated 
with persistent depression. Recently, it has been proposed 
that depressive symptomatology lies along a continuum 
of subsyndromal and prodromal stages of depressive dis-
orders  [35] . In light of our finding of an association be-
tween cerebrovascular lesions and depressive symptom-
atology, even below the threshold for major depressive 
disorder  [26] , such a continuum may well be related to 
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continuous alterations on a neurobiological level. Fur-
thermore, it has been suggested that residual symptoms 
of depression may be especially amenable to non-phar-
macological interventions beyond pharmacological treat-
ment effects  [36] , and this insight may be especially valu-
able in the study of post-ACS depression, since addition-
al factors – such as medication adherence  [37] , lifestyle 
adaptations to mitigate behavioral risk factors, and ad-
herence to other preventive measures – may strongly de-
pend upon individually tailored non-pharmacological 
interventions in this population  [38] .
 Despite its preliminary nature, this study establishes 
post-ACS depressive symptoms as ‘vascular’ depression 
 [1, 2] consistent with deep white matter hyperintensities 
and microstructural white matter abnormalities in the 
ACC. The identification of the neurobiological correlates 
of post-ACS depression can guide further investigation 
aimed at enhancing therapeutic interventions and disen-
tangling causal mechanisms in the relationship between 
depression and cardiovascular disease.
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